MedTrace Logo

Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery

NCT02213380 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 950

Last updated 2024-05-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is evaluate postoperative delirium after general anesthesia and regional anesthesia in elderly patients undergoing hip fracture surgery. Our research hypotheses are: (1) regional anesthesia may contribute to decrease the incidence of postoperative delirium. (2) Regional anesthesia may improve the outcome of elderly patient and reduce healthcare costs associated with postoperative delirium. (3) Postoperative delirium may result in poor long-term functional outcomes.

Conditions

  • Post Operative Delirium

Interventions

PROCEDURE

method of anesthesia

General anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA

Sponsors & Collaborators

  • National Research Institute for Family Planning, China

    collaborator OTHER_GOV

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Fang Gao, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

  • Qingquan Lian, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

  • Jun Li, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

  • Ting Li, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

  • Joice Yeung, M.D. · Heart of England NHS Foundation Trust

  • Teresa Moledy · Heart of England NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2018-12-31
Completion
2020-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213380 on ClinicalTrials.gov